Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 1
2005 1
2006 1
2007 1
2010 3
2011 4
2012 3
2013 2
2014 1
2015 1
2016 3
2017 4
2018 3
2019 2
2020 4
2021 3
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Low-Molecular-Weight Heparin and the Relative Risk of Surgical Site Bleeding Complications: Results of a Systematic Review and Meta-Analysis of Randomized Controlled Trials of Venous Thromboprophylaxis in Patients After Total Joint Arthroplasty.
Suen K, Westh RN, Churilov L, Hardidge AJ. Suen K, et al. J Arthroplasty. 2017 Sep;32(9):2911-2919.e6. doi: 10.1016/j.arth.2017.04.010. Epub 2017 Apr 14. J Arthroplasty. 2017. PMID: 28522244 Review.
BACKGROUND: Venous thromboembolism causes significant morbidity and mortality in patients after total joint arthroplasty. Although network meta-analyses have demonstrated a benefit of various thromboprophylactic agents, there remains a concern in the surgical community reg …
BACKGROUND: Venous thromboembolism causes significant morbidity and mortality in patients after total joint arthroplasty. Although ne …
Aspirin monotherapy is a suitable standard thromboprophylactic agent following total hip arthroplasty.
Borton ZM, Bhangoo NS, Quah CS, Stephen AB, Howard PW. Borton ZM, et al. Hip Int. 2022 May;32(3):286-290. doi: 10.1177/1120700021990544. Epub 2021 Feb 18. Hip Int. 2022. PMID: 33601921 Review.
Following our institution's previously published experience we implemented a risk-stratified protocol utilising aspirin as standard. We now present retrospective review of standard use of aspirin on fatal pulmonary embolism, all-cause mortality, and venous thromboem …
Following our institution's previously published experience we implemented a risk-stratified protocol utilising aspirin as standard. …
Venous Thromboembolism Prophylaxis in Major Orthopedic Surgeries and Factor XIa Inhibitors.
Jones A, Al-Horani RA. Jones A, et al. Med Sci (Basel). 2023 Aug 11;11(3):49. doi: 10.3390/medsci11030049. Med Sci (Basel). 2023. PMID: 37606428 Free PMC article. Review.
The choice of the initial agent depends on the specific surgery and patient comorbidities. First-line options include low-molecular-weight heparins (LMWHs), direct oral anticoagulants, and aspirin. Second-line options consist of unfractionated hepar
The choice of the initial agent depends on the specific surgery and patient comorbidities. First-line options include low-molecula
Aspirin for lower limb arthroplasty thromboprophylaxis: review of international guidelines.
Donohoe CL, Sayana MK, Thakral R, Niall DM. Donohoe CL, et al. Ir J Med Sci. 2011 Sep;180(3):627-32. doi: 10.1007/s11845-010-0658-0. Epub 2010 Dec 14. Ir J Med Sci. 2011. PMID: 21286842 Review.
INTRODUCTION: Aspirin is one of the pharmacological agents used for thromboprophylaxis. ...RESULTS: Two of five guidelines reviewed recommend the use of aspirin for thromboprophylaxis. Aspirin is used as thromboprophylactic agent in approximatel …
INTRODUCTION: Aspirin is one of the pharmacological agents used for thromboprophylaxis. ...RESULTS: Two of five guidelines rev …
Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trial.
Anderson DR, Dunbar MJ, Bohm ER, Belzile E, Kahn SR, Zukor D, Fisher W, Gofton W, Gross P, Pelet S, Crowther M, MacDonald S, Kim P, Pleasance S, Davis N, Andreou P, Wells P, Kovacs M, Rodger MA, Ramsay T, Carrier M, Vendittoli PA. Anderson DR, et al. Ann Intern Med. 2013 Jun 4;158(11):800-6. doi: 10.7326/0003-4819-158-11-201306040-00004. Ann Intern Med. 2013. PMID: 23732713 Clinical Trial.
BACKGROUND: The role of aspirin in thromboprophylaxis after total hip arthroplasty (THA) is controversial. ...Given its low cost and greater convenience, aspirin may be considered a reasonable alternative for extended thromboprophylaxi
BACKGROUND: The role of aspirin in thromboprophylaxis after total hip arthroplasty (THA) is controversial. ...Gi …
Systematic review of aspirin for thromboprophylaxis in modern elective total hip and knee arthroplasty.
Wilson DG, Poole WE, Chauhan SK, Rogers BA. Wilson DG, et al. Bone Joint J. 2016 Aug;98-B(8):1056-61. doi: 10.1302/0301-620X.98B8.36957. Bone Joint J. 2016. PMID: 27482017 Free article. Review.
AIMS: There is uncertainty regarding the optimal means of thromboprophylaxis following total hip and knee arthroplasty (THA, TKA). ...RESULTS: Evidence from one good quality randomised controlled trial (RCT) showed no difference in rates of venous thrombo-emb …
AIMS: There is uncertainty regarding the optimal means of thromboprophylaxis following total hip and knee arthroplasty
Venous thromboprophylaxis after total hip arthroplasty: aspirin, warfarin, enoxaparin, or factor Xa inhibitors?
Bala A, Murasko MJ, Burk DR, Huddleston JI 3rd, Goodman SB, Maloney WJ, Amanatullah DF. Bala A, et al. Hip Int. 2020 Sep;30(5):564-571. doi: 10.1177/1120700019841600. Epub 2019 Apr 16. Hip Int. 2020. PMID: 30990095
INTRODUCTION: Debate over the ideal agent for venous thromboembolism (VTE) prophylaxis after total hip arthroplasty (THA) has led to changes in prescribing trends of commonly used agents. We investigate variation in utilisation and the differences in VTE incidence a …
INTRODUCTION: Debate over the ideal agent for venous thromboembolism (VTE) prophylaxis after total hip arthroplasty (THA) has …
The effect of aspirin and low-molecular-weight heparin on venous thromboembolism after hip replacement: a non-randomised comparison from information in the National Joint Registry.
Jameson SS, Charman SC, Gregg PJ, Reed MR, van der Meulen JH. Jameson SS, et al. J Bone Joint Surg Br. 2011 Nov;93(11):1465-70. doi: 10.1302/0301-620X.93B11.27622. J Bone Joint Surg Br. 2011. PMID: 22058295 Free article.
We compared thromboembolic events, major haemorrhage and death after total hip replacement in patients receiving either aspirin or low-molecular-weight heparin (LMWH). ...With propensity score matching the mortality difference incr …
We compared thromboembolic events, major haemorrhage and death after total hip replacement in patients receiving either asp
Aspirin compared to enoxaparin or rivaroxaban for thromboprophylaxis following hip and knee replacement.
Ní Cheallaigh S, Fleming A, Dahly D, Kehoe E, O'Byrne JM, McGrath B, O'Connell C, Sahm LJ. Ní Cheallaigh S, et al. Int J Clin Pharm. 2020 Jun;42(3):853-860. doi: 10.1007/s11096-020-01032-1. Epub 2020 Apr 23. Int J Clin Pharm. 2020. PMID: 32328957
All eligible patients undergoing primary total hip or knee replacement between 1st January 2010 and 30th June 2016 were included. ...Aspirin can be considered a safe and effective agent in the prevention of venous thromboembolism after total hip or tot …
All eligible patients undergoing primary total hip or knee replacement between 1st January 2010 and 30th June 2016 were includ …
Aspirin for elective hip and knee arthroplasty: a multimodal thromboprophylaxis protocol.
Vulcano E, Gesell M, Esposito A, Ma Y, Memtsoudis SG, Gonzalez Della Valle A. Vulcano E, et al. Int Orthop. 2012 Oct;36(10):1995-2002. doi: 10.1007/s00264-012-1588-4. Epub 2012 Jun 12. Int Orthop. 2012. PMID: 22684546 Free PMC article.
METHODS: A total of 1,568 consecutive patients undergoing hip and knee replacement surgery received multimodal thromboprophylaxis: 1,115 received aspirin, 426 received warfarin and 27 patients received low molecular weight
METHODS: A total of 1,568 consecutive patients undergoing hip and knee replacement surgery received multimodal throm
39 results